News Industry News Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients Are Having A Heart Attack September 10, 2019
News Industry News Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure July 23, 2019
News Industry News New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events In Adults With No Known Heart Disease April 29, 2019
News Industry News Ortho's VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries April 16, 2019